Arcadia Biosciences (RKDA) Tops Q3 EPS by 19c

Arcadia Biosciences (NASDAQ: RKDA) reported Q3 EPS of ($0.10), $0.19 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $2.51 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance